Roche, other pharmas follow suit to halt price increases

Roche (SIX:ROG; OTCQX:RHHBY) is following the trend of suspending price increases in the U.S. for this year after President Donald Trump and HHS Secretary Alex Azar publicly demanded changes in drug pricing.

Roche said in a statement Friday that it

Read the full 396 word article

User Sign In